Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1133077 | 0.91 | CES2 (0.38) | CES2 | |
| SCHEMBL5072141 | 0.89 | — | — | |
| SCHEMBL37107 | 0.87 | CES2 (0.32) | CES2 | |
| SCHEMBL9417209 | 0.86 | THRB (0.36) | CES2 | |
| SCHEMBL8899377 | 0.86 | CES2 (0.35) | CES2 | |
| SCHEMBL1070988 | 0.84 | CES2 (0.34) | CES2 | |
| SCHEMBL213679 | 0.84 | — | — | |
| SCHEMBL4753558 | 0.83 | TSHR (0.32) | — | |
| SCHEMBL4264190 | 0.83 | TSHR (0.32) | — | |
| SCHEMBL1802118 | 0.83 | CES2 (0.30) | CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 243 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3049483-B1 | METAL EFFECT PIGMENTS MODIFIED WITH A SILANE LAYER CONTAINING AT LEAST TWO DIFFERENT BIFUNCTIONAL SILANES | SCHLENK METALLIC PIGMENTS GMBH (DE) | 2019-06-12 | — | — | EP | claimed |
| US-20160244615-A1 | METAL EFFECT PIGMENTS MODIFIED WITH A SILANE LAYER CONTAINING AT LEAST TWO DIFFERENT BIFUNCTIONAL SILANES | SCHLENK METALLIC PIGMENTS GMBH (DE) | 2016-08-25 | — | — | US | claimed |
| EP-3049483-A1 | METAL EFFECT PIGMENTS MODIFIED WITH A SILANE LAYER CONTAINING AT LEAST TWO DIFFERENT BIFUNCTIONAL SILANES | Schlenk Metallic Pigments GmbH (DE) | 2016-08-03 | — | — | EP | claimed |
| WO-2015044188-A1 | METAL EFFECT PIGMENTS MODIFIED WITH A SILANE LAYER CONTAINING AT LEAST TWO DIFFERENT BIFUNCTIONAL SILANES | SCHLENK METALLIC PIGMENTS GMBH (DE) | 2015-04-02 | — | — | WO | claimed |
| US-20100190637-A1 | Curing Catalyst | MERCK PATENT GESELLSCHAFT (DE) | 2010-07-29 | — | — | US | claimed |
| EP-2160239-A1 | CURING CATALYST | Merck Patent GmbH (DE) | 2010-03-10 | — | — | EP | claimed |
| WO-2009015713-A1 | CURING ACCELERATOR | MERCK PATENT GMBH (DE) | 2009-02-05 | — | — | WO | claimed |
| WO-2009000378-A1 | CURING CATALYST | MERCK PATENT GMBH (DE) | 2008-12-31 | — | — | WO | claimed |
| EP-0593297-B1 | Resin composition for coating and paint | HITACHI CHEMICAL CO LTD (JP) | 1997-04-16 | — | — | EP | claimed |
| EP-4007562-B1 | METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN ORGANIC C1-C6-ALKOXY-SILANE AND AN ALKALISING AGENT | HENKEL AG & CO KGAA (DE) | 2025-10-22 | — | — | EP | disclosed |
| EP-4007641-B1 | METHOD FOR TREATING KERATINOUS MATERIAL, COMPRISING THE USE OF AN ORGANIC C1-C6 ALKOXY SILANE AND AN AMINO ACID AND/OR AN AMINO ACID DERIVATIVE | HENKEL AG & CO KGAA (DE) | 2025-08-06 | — | — | EP | disclosed |
| US-12329840-B2 | Agent for dyeing keratin material, containing at least two organosilicon compounds that are different from each other, at least one pigment and at least one liquid fatty component and/or a solvent | HENKEL AG & CO. KGAA (DE) | 2025-06-17 | — | — | US | disclosed |
| US-20240342073-A1 | AGENT FOR DYEING KERATIN MATERIAL, IN PARTICULAR HUMAN HAIR, CONTAINING AMINOSILICONES AND PLATELET-TYPE METALLIC PIGMENTS | HENKEL AG & CO. KGAA (DE) | 2024-10-17 | — | — | US | disclosed |
| EP-4380540-A1 | AGENT FOR DYEING KERATIN MATERIAL, IN PARTICULAR HUMAN HAIR, CONTAINING AMINOSILICONES AND PLATELET-TYPE METALLIC PIGMENTS | Henkel AG & Co. KGaA (DE) | 2024-06-12 | — | — | EP | disclosed |
| US-5700874-A | CONJUGATED DIENE/VINYLAROMATIC HYDROCARBON COPOLYMER MODIFIED WITH ALKOXYSILANE | BRIDGESTONE CORPORATION (JP) | 1997-12-23 | — | — | US | disclosed |
| US-5580614-A | MIXING SOLUTION OF CHELATED ORGANOMETALLIC COMPOUND HAVING POLYMERIZABLE LIGANDS WITH A HYDROLYZATE OF RADICALLY POLYMERIZED ALKOXYSILANES AND A PHOTOINITIATOR, THEN COATING A SUBSTRATE AND CURING WITH RADIATION | FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 1996-12-03 | — | — | US | disclosed |
| EP-0524417-A1 | Coating composition and method for preparation of UV, UV/IR or IR/UV curable coatings | FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 1993-01-27 | — | — | EP | disclosed |
| US-4855180-A | Process for producing optical article having anti-reflection film | HOYA CORPORATION (JP) | 1989-08-08 | — | — | US | disclosed |
| US-4081421-A | Curable resin composition for abrasion-resistant coating | JAPAN ATOMIC ENERGY RESEARCH INSTITUTE (JA) | 1978-03-28 | — | — | US | disclosed |
| US-4026826-A | ALKOXYSILANES | JAPAN ATOMIC ENERGY RESEARCH INSTITUTE (JA) | 1977-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240342073-A1 | AGENT FOR DYEING KERATIN MATERIAL, IN PARTICULAR HUMAN HAIR, CONTAINING AMINOSILICONES AND PLATELET-TYPE METALLIC PIGMENTS | KRT18, ALG3, MKI67 | CES2 4715/4885 |
| US-12329840-B2 | Agent for dyeing keratin material, containing at least two organosilicon compounds that are different from each other, at least one pigment and at least one liquid fatty component and/or a solvent | KRT18, CUTA, DSG1 | CES2 3420/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.